Pathophysiology of insulin resistance.

Insulin resistance is a feature of a number of clinical disorders, including type 2 diabetes/glucose intolerance, obesity, dyslipidaemia and hypertension clustering in the so-called metabolic syndrome. Insulin resistance in skeletal muscle manifests itself primarily as a reduction in insulin-stimulated glycogen synthesis due to reduced glucose transport. Ectopic lipid accumulation plays an important role in inducing insulin resistance. Multiple defects in insulin signalling are responsible for impaired glucose metabolism in target tissues of subjects with features of insulin resistance. Inflammatory molecules and lipid metabolites inhibit insulin signalling by stimulating a number of different serine kinases which are responsible for serine phosphorylation of Insulin Receptor Substrate-1 (IRS-1).

[1]  S. Kane,et al.  A Method to Identify Serine Kinase Substrates , 2002, The Journal of Biological Chemistry.

[2]  H. Luthman,et al.  Regulation of human insulin receptor RNA splicing in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[4]  A. Vaag,et al.  Expression of insulin regulatable glucose transporters in skeletal muscle from Type 2 (non-insulin-dependent) diabetic patients , 1990, Diabetologia.

[5]  S. Lillioja,et al.  Correlation between muscle glycogen synthase activity and in vivo insulin action in man. , 1984, The Journal of clinical investigation.

[6]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[7]  P. Jansson,et al.  Insulin Signaling and Action in Fat Cells: Associations with Insulin Resistance and Type 2 Diabetes , 1999, Annals of the New York Academy of Sciences.

[8]  K. Jarnagin,et al.  The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling , 1985, Cell.

[9]  G. Sesti,et al.  Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms , 2001, Diabetes/metabolism research and reviews.

[10]  R. Longhi,et al.  Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein , 1994, Acta Diabetologica.

[11]  G. Sesti,et al.  Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects. , 1996, The Journal of clinical investigation.

[12]  William Arbuthnot Sir Lane,et al.  Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.

[13]  R. Shulman,et al.  Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D L Rothman,et al.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. , 1999, The Journal of clinical investigation.

[15]  H. Lodish,et al.  A glucose transport protein expressed predominately in insulin-responsive tissues. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Siddle,et al.  Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. , 1993, The Biochemical journal.

[17]  G. Sesti,et al.  Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients , 1997, Molecular and Cellular Endocrinology.

[18]  J. Silverman,et al.  Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. , 1986, The Journal of clinical investigation.

[19]  R. Henry,et al.  Insulin-Stimulated Protein Kinase C λ/ζ Activity Is Reduced in Skeletal Muscle of Humans With Obesity and Type 2 Diabetes: Reversal With Weight Reduction , 2003 .

[20]  D. Accili,et al.  Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients. , 1991, Biochemical and biophysical research communications.

[21]  L. Groop,et al.  Insulin receptor isotype expression correlates with risk of non-insulin-dependent diabetes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Birnbaum.  Identification of a novel gene encoding an insulin-responsive glucose transporter protein , 1989, Cell.

[23]  J. Colca,et al.  Reduced Expression of Hexokinase II in Insulin-Resistant Diabetes , 1995, Diabetes.

[24]  J. Olefsky,et al.  Relative expression of insulin receptor isoforms does not differ in lean, obese, and noninsulin-dependent diabetes mellitus subjects. , 1993, The Journal of clinical endocrinology and metabolism.

[25]  P. Arner,et al.  Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and Type 2 (non-insulin-dependent) diabetes mellitus , 1987, Diabetologia.

[26]  L. Groop,et al.  Insulin resistance in Type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle , 1992, Diabetologia.

[27]  F. Giorgino,et al.  Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. , 1995, The Journal of clinical investigation.

[28]  H. Luthman,et al.  Differences in the Ratio of RNA Encoding Two Isoforms of the Insulin Receptor Between Control and NIDDM Patients: The RNA Variant Without Exon 11 Predominates in Both Groups , 1993, Diabetes.

[29]  A. Ullrich,et al.  Functionally distinct insulin receptors generated by tissue‐specific alternative splicing. , 1990, The EMBO journal.

[30]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[31]  H. Maegawa,et al.  Impaired Autophosphorylation of Insulin Receptors From Abdominal Skeletal Muscles in Nonobese Subjects With NIDDM , 1991, Diabetes.

[32]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[33]  W. Pories,et al.  Insulin-Receptor Kinase Activity of Adipose Tissue From Morbidly Obese Humans With and Without NIDDM , 1987, Diabetes.

[34]  D. McClain.  Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action. , 1991, Molecular endocrinology.

[35]  J. Flier,et al.  Alternatively spliced variants of the insulin receptor protein. Expression in normal and diabetic human tissues. , 1992, The Journal of clinical investigation.

[36]  L. Orci,et al.  Lipotoxic diseases of nonadipose tissues in obesity , 2000, International Journal of Obesity.

[37]  J. Olefsky,et al.  Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. , 1994, The Journal of clinical endocrinology and metabolism.

[38]  J. Olefsky,et al.  A functional assessment of insulin/insulin-like growth factor-I hybrid receptors. , 1995, Endocrinology.

[39]  J. Flier,et al.  Ligand-binding properties of the two isoforms of the human insulin receptor. , 1993, Endocrinology.

[40]  G. Sesti,et al.  Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues , 1997, Molecular and Cellular Endocrinology.

[41]  Y. Kruszynska,et al.  Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects. , 1998, Diabetes.

[42]  B. Goldstein,et al.  Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. , 1997, Metabolism: clinical and experimental.

[43]  G. Dohm,et al.  Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance. , 2003, Diabetes.

[44]  G. Sesti,et al.  Increased abundance of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of obese subjects is correlated with in vivo insulin sensitivity. , 1998, The Journal of clinical endocrinology and metabolism.

[45]  R. Henry,et al.  Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. , 1999, The Journal of clinical investigation.

[46]  M. Sajan,et al.  Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise. , 2003, Diabetes.

[47]  A. Ullrich,et al.  Evidence That Two Naturally Occurring Human Insulin Receptor α-Subunit Variants Are Immunologically Distinct , 1992, Diabetes.

[48]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[49]  R. Longhi,et al.  Peptide-based radioimmunoassay for the two isoforms of the human insulin receptor , 1995, Diabetologia.

[50]  J. Zierath,et al.  Insulin Receptor Substrate-1 Phosphorylation and Phosphatidylinositol 3-Kinase Activity in Skeletal Muscle From NIDDM Subjects After In Vivo Insulin Stimulation , 1997, Diabetes.

[51]  A. Vaag,et al.  Reduced glycogen synthase activity in skeletal muscle from obese patients with and without Type 2 (non-insulin-dependent) diabetes mellitus , 1991, Diabetologia.

[52]  R. Farese,et al.  Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. , 2002, American journal of physiology. Endocrinology and metabolism.

[53]  K. Petersen,et al.  Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.

[54]  B. Goldstein,et al.  Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. , 1995, The Journal of clinical investigation.

[55]  J. Zierath,et al.  Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. , 2000, Diabetes.

[56]  D. James,et al.  Molecular cloning and characterization of an insulin-regulatable glucose transporter , 1989, Nature.

[57]  C. Kahn,et al.  Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. , 2001, Molecular cell.

[58]  A. Klip,et al.  Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM , 1996, Diabetologia.

[59]  R. Shulman,et al.  31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[60]  A. Klip,et al.  Insulin induces translocation of GLUT-4 glucose transporters in human skeletal muscle. , 1995, The American journal of physiology.

[61]  P. Vollenweider,et al.  Impaired activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 in cultured preadipocyte-derived adipocytes and myotubes of obese subjects. , 2004, The Journal of clinical endocrinology and metabolism.

[62]  G. Sesti,et al.  Expression of Insulin/IGF-I Hybrid Receptors Is Increased in Skeletal Muscle of Patients With Chronic Primary Hyperinsulinemia , 1998, Diabetes.

[63]  Richard J Sciotti,et al.  Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. , 2003, Diabetes.

[64]  K. Petersen,et al.  Nuclear magnetic resonance studies of hepatic glucose metabolism in humans. , 2001, Recent progress in hormone research.

[65]  P. H. Seeburg,et al.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.

[66]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[67]  C Collins,et al.  Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.

[68]  G. Dohm,et al.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. , 1987, The Journal of clinical investigation.

[69]  D. Reese,et al.  Insulin-inducible changes in insulin receptor mRNA splice variants. , 1994, The Journal of biological chemistry.

[70]  G. Dohm,et al.  Skeletal Muscle Content of Membrane Glycoprotein PC-1 in Obesity: Relationship to Muscle Glucose Transport , 1996, Diabetes.

[71]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[72]  G. Dohm,et al.  Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. , 1997, The Journal of clinical investigation.

[73]  B. Kahn,et al.  Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. , 1999, The New England journal of medicine.

[74]  R. Vigneri,et al.  Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-a gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity , 1997, Diabetologia.

[75]  K. Petersen,et al.  13C/31P NMR studies on the mechanism of insulin resistance in obesity. , 1998, Diabetes.

[76]  R. DeFronzo,et al.  Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance. , 2000, The Journal of clinical endocrinology and metabolism.

[77]  F. Schick,et al.  Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. , 1999, Diabetes.

[78]  Z Trajanoski,et al.  Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.

[79]  G. Dohm,et al.  An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. , 1988, The Journal of clinical investigation.

[80]  G. Pandini,et al.  Insulin/insulin-like growth factor I hybrid receptors overexpression is not an early defect in insulin-resistant subjects. , 2000, The Journal of clinical endocrinology and metabolism.

[81]  Simon C Watkins,et al.  The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. , 1996, The Journal of clinical investigation.

[82]  A. Baron,et al.  Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. , 1998, The Journal of clinical investigation.

[83]  M. White,et al.  IRS proteins and the common path to diabetes. , 2002, American journal of physiology. Endocrinology and metabolism.

[84]  J. Youngren,et al.  Role of PC‐1 in The Etiology of Insulin Resistance , 1999, Annals of the New York Academy of Sciences.

[85]  G. Sesti,et al.  Defects of the insulin receptor substrate (IRS) system in human metabolic disorders , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[86]  A. Ullrich,et al.  Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[87]  J. Pickup.  Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. , 2004, Diabetes care.

[88]  J. Flier,et al.  Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells. , 1991, Endocrinology.

[89]  Y. Le Marchand-Brustel,et al.  Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. , 2003, Diabetes.

[90]  P. Shier,et al.  Primary structure of a putative receptor for a ligand of the insulin family. , 1989, The Journal of biological chemistry.

[91]  G. Sesti,et al.  Altered pattern of insulin receptor isotypes in skeletal muscle membranes of Type 2 (non-insulin-dependent) diabetic subjects , 1993, Diabetologia.

[92]  J. Zierath,et al.  Insulin-Stimulated Akt Kinase Activity Is Reduced in Skeletal Muscle From NIDDM Subjects , 1998, Diabetes.

[93]  J. Friedman,et al.  Decreased expression of glucose transporter in muscle from insulin-resistant patients. , 1991, The American journal of physiology.

[94]  T. Hansen,et al.  Expression of insulin receptor spliced variants and their functional correlates in muscle from patients with non-insulin-dependent diabetes mellitus. , 1993, The Journal of clinical endocrinology and metabolism.

[95]  M. Czech,et al.  Signaling Mechanisms That Regulate Glucose Transport* , 1999, The Journal of Biological Chemistry.

[96]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[97]  J. Zierath,et al.  Insulin action and insulin resistance in human skeletal muscle , 2000, Diabetologia.

[98]  John M Asara,et al.  Insulin-stimulated Phosphorylation of a Rab GTPase-activating Protein Regulates GLUT4 Translocation* , 2003, The Journal of Biological Chemistry.